Randomised controlled field study to evaluate the efficacy and clinical safety of a single 8 mg/ kg injectable dose of marbofloxacin compared with one or two doses of 7.5 mg/ kg injectable enrofloxacin for the treatment of Actinobacillus pleuropleumoniae infections in growing-fattening pigs in Europe
Acute outbreaks of Actinobacillus pleuropneumoniae (APP) require rapid, effective, parenteral antimicrobial treatment. The efficacy of a single, short-acting, high-dose marbofloxacin (Forcyl (R) swine160 mg/ ml) compared with 1 or 2 doses of 7.5 mg/ kg enrofloxacin in APP outbreaks in European farms was studied.
DATE » 06.06.2017
AUTHORS » Erik Grandemange, Pierre-Alexandre Perrin, Dejan Cvejic, Miriam Haas, Tim Rowan, Klaus Hellmann